Recent Securities Litigations

Oasmia Pharmaceutical AB (NASDAQ: OASM)

Company Name:Oasmia Pharmaceutical AB
Stock Symbol:NASDAQ: OASM
Class Period Start:10/23/2015
Class Period End (inclusive):10/14/2019

According to the Complaint, Oasmia purports to be a pharmaceutical company focused on innovative treatments within human and animal oncology.

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Oasmia engaged in improper related-party transactions with Alceco International S.A. and Ardenia Investment LTD, which were controlled by one of the Individual Defendants and his former father-in-law; (2) due to those transactions, millions of Swedish kronor were not accounted for in Oasmia's books; (3) transactions concerning Oasmia's patents were also "carried out in a doubtful way;" and (4) as a result of the aforementioned misconduct, Defendants' statements about Oasmia's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.